PYOTT DAVID E I — SEC insider filings

SEC reporting owner CIK 1051578. 28 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 28 filings on record, filed 2020-09-01 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ALNYLAM PHARMACEUTICALS, INC. (ALNY)Director12—9 legs · 43,720 sh · $10,531,77323
BIOMARIN PHARMACEUTICAL INC (BMRN)Director52 legs · 12,800 sh · $1,001,715—4
Tarsus Pharmaceuticals, Inc. (TARS)Director4——9
PLIANT THERAPEUTICS, INC. (PLRX)Director7——7

Insider filings — PYOTT DAVID E I

FiledFormIssuerReported transactionsSource
2026-11-124ALNYLAM PHARMACEUTICALS, INC. (ALNY)Option exercise (M): 3,780 @ $71.99 · Option exercise (M): 3,780 (derivative) @ $0EDGAR
2026-09-174Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 201 · Option exercise (M): 201 (derivative) @ $0EDGAR
2026-06-294Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 3,837 (derivative) @ $0 · Grant/award (A): 2,417 (derivative) @ $0 · Grant/award (A): 806 (derivative) @ $0EDGAR
2026-06-034ALNYLAM PHARMACEUTICALS, INC. (ALNY)Option exercise (M): 3,830 @ $0 · Sale (S): 921 @ $297.71 · Sale (S): 1,175 @ $298.91 · Sale (S): 1,222 @ $299.87 · Sale (S): 495 @ $300.72 · Sale (S): 17 @ $302.65 · +1 moreEDGAR
2026-05-224ALNYLAM PHARMACEUTICALS, INC. (ALNY)Grant/award (A): 671 @ $0 · Grant/award (A): 1,441 (derivative) @ $0EDGAR
2026-04-284Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 1,383 · Option exercise (M): 1,383 (derivative) @ $0EDGAR
2026-02-204Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 5,893 (derivative) @ $0 · Grant/award (A): 3,729 (derivative) @ $0EDGAR
2025-06-094PLIANT THERAPEUTICS, INC. (PLRX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-05-124ALNYLAM PHARMACEUTICALS, INC. (ALNY)Grant/award (A): 775 @ $0 · Grant/award (A): 1,558 (derivative) @ $0EDGAR
2025-03-254ALNYLAM PHARMACEUTICALS, INC. (ALNY)Option exercise (M): 7,440 @ $88.95 · Sale (S): 7,440 @ $299 · Option exercise (M): 7,440 (derivative) @ $0EDGAR
2024-06-264ALNYLAM PHARMACEUTICALS, INC. (ALNY)Option exercise (M): 17,560 @ $88.95 · Option exercise (M): 7,420 @ $70.20 · Option exercise (M): 7,470 @ $71.99 · Sale (S): 17,560 @ $220 · Sale (S): 7,420 @ $221 · Sale (S): 7,470 @ $222 · +3 moreEDGAR
2024-06-174PLIANT THERAPEUTICS, INC. (PLRX)Grant/award (A): 26,764 (derivative) @ $0EDGAR
2024-05-234BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 4,720 @ $0EDGAR
2024-05-204ALNYLAM PHARMACEUTICALS, INC. (ALNY)Grant/award (A): 5,228 (derivative) @ $0EDGAR
2023-06-084PLIANT THERAPEUTICS, INC. (PLRX)Grant/award (A): 14,000 (derivative) @ $0EDGAR
2023-05-244BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 4,190 @ $0EDGAR
2023-05-194ALNYLAM PHARMACEUTICALS, INC. (ALNY)Grant/award (A): 3,454 (derivative) @ $0EDGAR
2023-02-274ALNYLAM PHARMACEUTICALS, INC. (ALNY)Option exercise (M): 136 @ $0 · Option exercise (M): 136 (derivative) @ $0EDGAR
2022-06-214PLIANT THERAPEUTICS, INC. (PLRX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-05-264BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 4,980 @ $0EDGAR
2022-05-204ALNYLAM PHARMACEUTICALS, INC. (ALNY)Grant/award (A): 5,153 (derivative) @ $0EDGAR
2022-02-254ALNYLAM PHARMACEUTICALS, INC. (ALNY)Grant/award (A): 136 (derivative) @ $0EDGAR
2021-07-194ALNYLAM PHARMACEUTICALS, INC. (ALNY)Grant/award (A): 4,032 (derivative) @ $0EDGAR
2021-07-014/APLIANT THERAPEUTICS, INC. (PLRX)Grant/award (A): 13,286 (derivative) @ $0EDGAR
2021-06-304PLIANT THERAPEUTICS, INC. (PLRX)Grant/award (A): 13,286 (derivative) @ $0EDGAR
2021-05-274BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 5,120 @ $0EDGAR
2021-01-134PLIANT THERAPEUTICS, INC. (PLRX)Grant/award (A): 26,573 (derivative) @ $0EDGAR
2020-09-014BIOMARIN PHARMACEUTICAL INC (BMRN)Purchase (P): 11,900 @ $78.22 · Purchase (P): 900 @ $78.84EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1051578 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs